These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 20067840)

  • 1. Mitochondrial medicine for neurodegenerative diseases.
    Du H; Yan SS
    Int J Biochem Cell Biol; 2010 May; 42(5):560-72. PubMed ID: 20067840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial medicine for aging and neurodegenerative diseases.
    Reddy PH
    Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders.
    Rahman MM; Tumpa MAA; Rahaman MS; Islam F; Sutradhar PR; Ahmed M; Alghamdi BS; Hafeez A; Alexiou A; Perveen A; Ashraf GM
    Curr Neuropharmacol; 2023; 21(5):1081-1099. PubMed ID: 36927428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Treatment Strategies for Mitochondria Dysfunction: Correlation with Neurological Disorders.
    Sharma R; Malviya R; Srivastava S; Ahmad I; Rab SO; Uniyal P
    Curr Drug Targets; 2024; 25(10):683-699. PubMed ID: 38910425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.
    Pienaar IS; Schallert T; Hattingh S; Daniels WM
    J Neural Transm (Vienna); 2009 Jul; 116(7):791-806. PubMed ID: 19504041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal oscillations: A physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases?
    Chan F; Lax NZ; Davies CH; Turnbull DM; Cunningham MO
    Neuropharmacology; 2016 Mar; 102():48-58. PubMed ID: 26518370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial medicine: pharmacological targeting of mitochondria in disease.
    Armstrong JS
    Br J Pharmacol; 2007 Aug; 151(8):1154-65. PubMed ID: 17519949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Biology and Neurological Diseases.
    Arun S; Liu L; Donmez G
    Curr Neuropharmacol; 2016; 14(2):143-54. PubMed ID: 26903445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial respiratory chain dysfunction: implications in neurodegeneration.
    Morán M; Moreno-Lastres D; Marín-Buera L; Arenas J; Martín MA; Ugalde C
    Free Radic Biol Med; 2012 Aug; 53(3):595-609. PubMed ID: 22595027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C
    Gonchar OO; Maznychenko AV; Klyuchko OM; Mankovska IM; Butowska K; Borowik A; Piosik J; Sokolowska I
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration.
    Cassarino DS; Bennett JP
    Brain Res Brain Res Rev; 1999 Jan; 29(1):1-25. PubMed ID: 9974149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons.
    El-Mir MY; Detaille D; R-Villanueva G; Delgado-Esteban M; Guigas B; Attia S; Fontaine E; Almeida A; Leverve X
    J Mol Neurosci; 2008; 34(1):77-87. PubMed ID: 18040888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of melatonin in mitochondrial dysfunction and related disorders.
    Paradies G; Paradies V; Ruggiero FM; Petrosillo G
    Arch Toxicol; 2015 Jun; 89(6):923-39. PubMed ID: 25690732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives of drug-based neuroprotection targeting mitochondria.
    Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P
    Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the pathophysiology of neurodegenerative disorders.
    Willner C
    Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidative stress treatment for clinical trials in neurodegenerative diseases.
    Ienco EC; LoGerfo A; Carlesi C; Orsucci D; Ricci G; Mancuso M; Siciliano G
    J Alzheimers Dis; 2011; 24 Suppl 2():111-26. PubMed ID: 21422516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases.
    Keating DJ
    J Neurochem; 2008 Jan; 104(2):298-305. PubMed ID: 17961149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.